The Day Shorters Room

[Warhorse]

G E R N! READ the friggin news boys! (COMTEX) B: Financial Relations Inc: Geron Wins Stem Cell Technology Paten
and HemoSense Signs Exclusive Distribution Agreement
B: Financial Relations Inc: Geron Wins Stem Cell Technology Patent and HemoSense
Signs Exclusive Distribution Agreement with Cardinal Health ( M2 PRESSWIRE )

Oct 06, 2004 (M2 PRESSWIRE via COMTEX) -- City of Industry, CA - HemoSense,
Inc. recently announced the signing of an exclusive three-year agreement with
Cardinal Health, Inc. (NYSE:CAH) to market, sell and distribute HemoSense's
INRatio product line to health-care providers in the United States. Under the
agreement, Cardinal Health will provide the INRatio product line to physician
offices, clinics, surgery centers, and ambulatory centers within integrated
delivery networks (IDNs). Financial terms were not disclosed. Geron Corporation
(NASDAQ: GERN) announced today that it has been granted U.S. Patent No.
6,800,480, covering the growth of human embryonic stem cells (hESCs) in the
absence of feeder cells. The technology covered by the new patent will greatly
facilitate scalable commercial manufacture of hESC-based therapeutic products.

U.S. BioDefense, Inc. (OTCBB: UBDF) announced recently that the company had
retained the business planning services of TriTech. TriTech is a Small Business
Development Center centered on helping Southern California people with
high-tech/high-growth business concepts learn how to bring their ideas to
market. U.S. BioDefense also recently announced the Defense Logistics Agency
partnership, a tier of the Department of Defense for the United States of
America. Partners with a Central Contractor Registration number have exclusive
access to contract with various US Government Agencies which in turn increases
potential sales opportunities for U.S. BioDefense.

About Financial Relations, Inc.

Through a comprehensive financial communications program, we assist our client
companies capitalize on greater exposure to Wall Street. They have experienced
improved liquidity and increased trading volume to help improve capital access.

Regardless of a company`s size, age or track record, they can establish a
broader, more diverse audience for their investment idea. Financial Relations,
Inc. combines the most thorough combination of skills, strategies and superb
execution vital to an aggressive and effective financial communications program.
We put our vast expertise and resources to work for our clients - partnering to
achieve tangible results and measurable success. Financial Relations, Inc.
charges each client $10,000 in cash for news distribution may have an equity
position of up to 4.9% in the companies mentioned herein and may buy or sell the
stock any time. Please visit our Section 17B disclaimer at
www.financialrelationsinc.com/disclaimer.html

CONTACT: Financial Relations, Inc. Tel: [phone] e-mail:
[e-mail]

M2 Communications Ltd disclaims all liability for information provided within M2
PressWIRE. Data supplied by named party/parties. Further information on M2
PressWIRE can be obtained at http://www.presswire.net on the world wide web.
Inquiries to [e-mail].



(C)1994-2004 M2 COMMUNICATIONS LTD

-0-



*** end of story ***